Go Pro
Tara Bancroft

Tara Bancroft Analyst Performance

Director, Senior Analyst, Biotech Equity Research at TD Cowen

Tara Bancroft is a stock analyst at TD Cowen in the healthcare sector, covering 10 publicly traded companies. Over the past year, Tara Bancroft has issued 11 stock ratings, including buy and hold recommendations. While full access to Tara Bancroft's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Tara Bancroft's coverage history, rating activity, and performance tendencies - helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
12 Last 1 Years
Buy Recommendations
75.00% 9 Buy Ratings
Companies Covered
10 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy0.0%0 ratings
Buy75.0%9 ratings
Hold25.0%3 ratings
Sell0.0%0 ratings

Out of 12 total stock ratings issued by Tara Bancroft at TD Cowen, the majority (75.0%) have been Buy recommendations, followed by 25.0% Hold.

Exchange Coverage

ExchangePercentageCount
NASDAQ
90.0% of companies on NASDAQ
9 companies
NYSE
10.0% of companies on NYSE
1 company

Tara Bancroft, an analyst at TD Cowen, currently covers 10 companies listed on NASDAQ and NYSE, with the majority traded on NASDAQ.

Coverage Focus

Sector IconSectorPercentage
Healthcare
10 companies
100.0%

Tara Bancroft of TD Cowen specializes in stock coverage within the Healthcare sector.

Coverage Industries

IndustryPercentage
BIOTECHNOLOGY
5 companies
50.0%
PHARMACEUTICALS
5 companies
50.0%

Tara Bancroft's Ratings History at TD Cowen

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Arcus Biosciences, Inc. stock logo
RCUS
Arcus Biosciences
9/16/2026Initiated Coverage$24.23Buy
Sensei Biotherapeutics, Inc. stock logo
FTH
Sensei Biotherapeutics
9/9/2026Initiated Coverage$39.61Buy
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
9/2/2026Downgrade$4.58$4.00Hold
Urogen Pharma stock logo
URGN
Urogen Pharma
8/5/2026Boost Price Target$46.54$60.00Buy
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
8/3/2026Downgrade$101.88$102.50Hold
Kalaris Therapeutics Inc. stock logo
KLRS
Kalaris Therapeutics
6/15/2026Initiated Coverage$4.33Buy
Mineralys Therapeutics, Inc. stock logo
MLYS
Mineralys Therapeutics
4/27/2026Initiated Coverage$27.51Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
3/6/2026Downgrade$21.20Hold
Protagonist Therapeutics, Inc. stock logo
PTGX
Protagonist Therapeutics
2/26/2026Boost Price Target$86.84$100.00Buy
Day One Biopharmaceuticals, Inc. stock logo
DAWN
Day One Biopharmaceuticals
1/13/2026Initiated Coverage$10.99$34.00Buy
Ocular Therapeutix, Inc. stock logo
OCUL
Ocular Therapeutix
10/30/2025Boost Price Target$11.83$20.00Buy
Lantheus Holdings, Inc. stock logo
LNTH
Lantheus
9/15/2025Lower Price Target$52.48$80.00Buy